Journal article · 2025 · Open access
Synthesis and biological evaluation of novel benzohydrazide derivatives of substituted quinazoline-2,4(1H,3H)-diones as Selective PARP-1 inhibitors with promising anti-proliferative activity
Journal of Molecular Structure, 1349, 143667 · Published 20 August 2025 · DOI 10.1016/j.molstruc.2025.143667
In brief
“Synthesis and biological evaluation of novel benzohydrazide derivatives of substituted quinazoline-2,4(1H,3H)-diones as Selective PARP-1 inhibitors with promising anti-proliferative activity” is a 2025 journal article by Samar S. Tawfik and 6 co-authors, published in Journal of Molecular Structure. OpenAlex counts 4 citations as of 19 November 2026, which puts it in the top 3% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Molecular Structure.
- Citations
- 4
- Most cited in
- 2026 (4)
- Field-weighted impact
- 1.33
- References
- 62
- Authors
- 7
Abstract
Poly(ADP-ribose) polymerase-1 (PARP-1) is a promising target for anticancer therapy. In this study, seventeen novel substituted quinazolin-2,4(1 H ,3 H )-dione derivatives were rationally designed, synthesized, and evaluated for their anti-proliferative activity against human cancer cell lines HCT-116, MCF-7, and PC3. Among these, compounds 7a and 7e exhibited the most potent cytotoxic effects, with EC₅₀ values ranging from 2.95 to 10.03 μM. They exhibited selective cytotoxicity towards tumor cell lines compared to normal cell lines, with EC 50 values of 87.92 ± 4.1 μM and 51.84 ± 2.9 μM, respectively, against WI38 cell lines. Mechanistic studies, including enzymatic assays, showed both compounds to be selective inhibitors of PARP-1 over PARP-2. where 7a and 7e showed PARP-1 inhibitory EC₅₀ values of 0.068 ± 0.0027 μM and 0.024 ± 0.0009 μM, respectively, compared to Olaparib (0.040 ± 0.002 μM) . For PARP-2, 7a and 7e exhibited EC₅₀ = 0.357 ± 0.014 μM and 0.119 ± 0.005 μM, respectively, confirming their selectivity. In DNA-trapping experiments, 7a and 7e demonstrated EC₅₀ = 2.720 μM and 0.890 μM, respectively. According to molecular docking studies, both compounds bind to PARP-2 less favorably and occupy the PARP-1 active site similarly to Olaparib, forming important π-π stacking and hydrogen-bonding interactions. In contrast to the unstable binding seen in the PARP-2 complex, molecular dynamics simulations conducted over a 50 ns period further confirmed that 7a binds selectively to PARP-1, exhibiting stable interactions and few conformational fluctuations. Favorable pharmacokinetic profiles, such as high oral bioavailability, drug-likeness, and the lack of anticipated hepatotoxicity, CNS liability, or carcinogenicity, were predicted by in silico ADMET analysis for 7a and 7e . When taken as a whole, these results show that 7a and 7e are promising lead compounds for the creation of selective PARP-1 inhibitors for cancer treatment.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Tawfik, S. S., Elhanafy, E., Almehmadi, S. J., Ewes, W. A., Elkamhawy, A., Elokely, K. M., & Elfeky, S. M. (2025). Synthesis and biological evaluation of novel benzohydrazide derivatives of substituted quinazoline-2,4(1H,3H)-diones as Selective PARP-1 inhibitors with promising anti-proliferative activity. Journal of Molecular Structure, 1349, 143667. https://doi.org/10.1016/j.molstruc.2025.143667
MLA 9
Tawfik, Samar S., et al. “Synthesis and biological evaluation of novel benzohydrazide derivatives of substituted quinazoline-2,4(1H,3H)-diones as Selective PARP-1 inhibitors with promising anti-proliferative activity.” Journal of Molecular Structure, vol. 1349, 2025, p. 143667. https://doi.org/10.1016/j.molstruc.2025.143667.
Chicago
Tawfik, Samar S., Eslam Elhanafy, Samar J. Almehmadi, Wafaa A Ewes, Ahmed Elkamhawy, Khaled M. Elokely, and Sherin M. Elfeky. 2025. “Synthesis and biological evaluation of novel benzohydrazide derivatives of substituted quinazoline-2,4(1H,3H)-diones as Selective PARP-1 inhibitors with promising anti-proliferative activity.” Journal of Molecular Structure 1349: 143667. https://doi.org/10.1016/j.molstruc.2025.143667.
Harvard
Tawfik, S. S. et al. (2025) ‘Synthesis and biological evaluation of novel benzohydrazide derivatives of substituted quinazoline-2,4(1H,3H)-diones as Selective PARP-1 inhibitors with promising anti-proliferative activity’, Journal of Molecular Structure, 1349, p. 143667. doi:10.1016/j.molstruc.2025.143667.
IEEE
S. S. Tawfik et al., “Synthesis and biological evaluation of novel benzohydrazide derivatives of substituted quinazoline-2,4(1H,3H)-diones as Selective PARP-1 inhibitors with promising anti-proliferative activity,” Journal of Molecular Structure, vol. 1349, p. 143667, 2025, doi: 10.1016/j.molstruc.2025.143667.
BibTeX
@article{tawfik2025synthesis,
title = {{Synthesis and biological evaluation of novel benzohydrazide derivatives of substituted quinazoline-2,4(1H,3H)-diones as Selective PARP-1 inhibitors with promising anti-proliferative activity}},
author = {Tawfik, Samar S. and Elhanafy, Eslam and Almehmadi, Samar J. and Ewes, Wafaa A and Elkamhawy, Ahmed and Elokely, Khaled M. and Elfeky, Sherin M.},
journal = {Journal of Molecular Structure},
year = {2025},
volume = {1349},
pages = {143667},
doi = {10.1016/j.molstruc.2025.143667},
url = {https://doi.org/10.1016/j.molstruc.2025.143667}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- PARP-1 inhibitors
- benzohydrazide derivatives
- quinazoline-2,4(1H,3H)-diones
- anticancer agents
- cytotoxicity
- DNA trapping
- olaparib
- molecular docking
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Tawfik, S. S., Elhanafy, E., Almehmadi, S. J., Ewes, W. A., Elkamhawy, A., Elokely, K. M., & Elfeky, S. M. (2025). Synthesis and biological evaluation of novel benzohydrazide derivatives of substituted quinazoline-2,4(1H,3H)-diones as Selective PARP-1 inhibitors with promising anti-proliferative activity. Journal of Molecular Structure, 1349, 143667. https://doi.org/10.1016/j.molstruc.2025.143667
How many times has this paper been cited?
4 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Molecular Structure: sign in and open the full text from this page.
Who wrote this paper?
Samar S. Tawfik, Eslam Elhanafy, Samar J. Almehmadi, Wafaa A Ewes, Ahmed Elkamhawy, Khaled M. Elokely, Sherin M. Elfeky.
What is the DOI of this paper?
10.1016/j.molstruc.2025.143667, permanently at https://doi.org/10.1016/j.molstruc.2025.143667. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.